Related Experiment Video
Updated: Jul 15, 2026

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro
Published on: June 16, 2022
Recombinant soluble receptor activator of nuclear factor-kappaB inhibits parathyroid hormone-induced
Bao-Li Wang1, Hui Liang, Fang Zheng
1Institute of Endocrinology, Tianjin Medical University, Tianjin, China. bliwang72@yahoo.com.cn
Abstract:
The recent identification of receptor activator of nuclear factor-kappaB ligand (RANKL)/RANK/osteoprotegerin (OPG) cytokine system has led to a new molecular perspective on osteoclast biology and bone homeostasis. Specifically, the interaction between RANKL and RANK is responsible for osteoclast differentiation. In the present study, we evaluated whether soluble RANK (sRANK) could act as an antagonist of RANKL and down-regulate osteoclastogenesis and bone resorption in vitro. The prokaryotic expression vector coding for sRANK was constructed. Then the construct was introduced into E. coli Origami B (DE3) competent cells and recombinant sRANK was successfully produced and purified through affinity chromatography. sRANK reduced osteoclast-like cell (OLC) formation and resorption pit formation induced by parathyroid hormone (PTH) in a dose-dependent manner. In addition, sRANK significantly inhibited PTH-induced mRNA expression of carbonic anhydrase II and tartrate-resistant acid phosphatase in murine bone marrow cells as confirmed by using semi-quantitative RT-PCR. The down-regulation was highly correlated with the effect of sRANK on OLC formation from marrow cells. These data demonstrate the anti-resorptive effects of sRANK in vitro and highlight the potential of sRANK as a novel therapeutic approach to bone disorders characterized by enhanced bone resorption.
Insights
Soluble RANK (sRANK) effectively inhibits osteoclast formation and bone resorption by blocking RANKL signaling. This finding highlights sRANK
Area of Science:
- Bone Biology and Homeostasis
- Molecular Endocrinology
- Cellular Signaling
Background:
- The receptor activator of nuclear factor-kappaB ligand (RANKL)/RANK/osteoprotegerin (OPG) system is crucial for osteoclast differentiation and bone homeostasis.
- RANKL binding to RANK mediates osteoclastogenesis, making this interaction a target for therapeutic intervention.
Purpose of the Study:
- To investigate the potential of soluble RANK (sRANK) as an antagonist of RANKL.
- To evaluate the efficacy of sRANK in down-regulating osteoclastogenesis and bone resorption in vitro.
Main Methods:
- Construction and prokaryotic expression of a vector encoding sRANK.
- Purification of recombinant sRANK using affinity chromatography.
- In vitro assessment of sRANK's effects on osteoclast-like cell (OLC) formation, resorption pit formation, and gene expression (carbonic anhydrase II, TRAP) induced by parathyroid hormone (PTH).
Main Results:
- Recombinant sRANK was successfully produced and purified.
- sRANK demonstrated a dose-dependent reduction in PTH-induced OLC formation and resorption.
- sRANK significantly inhibited PTH-induced mRNA expression of key osteoclast markers in murine bone marrow cells.
Conclusions:
- sRANK exhibits significant anti-resorptive effects in vitro.
- sRANK has potential as a novel therapeutic agent for bone disorders characterized by excessive bone resorption.
Related Concept Videos
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Osteoclasts in Bone Remodeling
The Parathyroid Glands
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by producing...
Skeleton and Calcium Homeostasis
Synthesis and Functions of Calcitonin
The exact mechanisms by which calcitonin operates in calcium homeostasis remain elusive, but its significance is evident in several vital...
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
